International Immunology, Vol 10, 1837-1845, Copyright © 1998 by Oxford University Press
C Hoflich, WD Docke, A Busch, F Kern and HD Volk
An important aspect of peripheral T cell development is the differentiation
from naive into memory cells. To distinguish naive from memory cells,
CD45RA and CD11a are commonly used: CD45RA+ or CD11a(dim) T cells are
regarded as naive, while CD45RA- or CD11a(bright) T cells are thought to be
of memory type. There is, however, a CD8+ T cell subset which is CD45RA+
and at the same time CD11a(bright). It increases with age and in patients
with systemic viral infections, though its functional role in the immune
response is unknown. In the present study, we give evidence that this
subset is related to memory- like T cells as it produces IFN-gamma and
tumor necrosis factor-alpha, contains high levels of perforin, and
expresses CD95 in the same way as memory-type CD45RA-/CD11a(bright) CD8+ T
cells. Since it contains a high percentage of CD28- and CD57+ cells, is
increased in size and granularity, and is transiently expressed following
in vitro stimulation of naive CD8+ T cells, we speculate that this subset
mainly represents recently activated effector T cells that are able to
interact with CD80 and CD86 (B7-1 and B7-2 respectively) negative tissue
cells.
ARTICLES
CD45RA(bright)/CD11a(bright) CD8+ T cells: effector T cells [In Process Citation]
Institute of Medical Immunology, University Hospital Charite, Campus Mitte, Berlin, Germany.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. B. Walker, D. Haley, W. Miller, K. Floyd, K. P. Wisner, N. Sanjuan, H. Maecker, P. Romero, H.-M. Hu, W. G. Alvord, et al. gp100209-2M Peptide Immunization of Human Lymphocyte Antigen-A2+ Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8+ T Cells Clin. Cancer Res., January 15, 2004; 10(2): 668 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suarez, L. Mozo, and C. Gutierrez Generation of CD4+CD45RA+ Effector T Cells by Stimulation in the Presence of Cyclic Adenosine 5'-Monophosphate- Elevating Agents J. Immunol., August 1, 2002; 169(3): 1159 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. G. Marcondes, E. M. E. Burudi, S. Huitron-Resendiz, M. Sanchez-Alavez, D. Watry, M. Zandonatti, S. J. Henriksen, and H. S. Fox Highly Activated CD8+ T Cells in the Brain Correlate with Early Central Nervous System Dysfunction in Simian Immunodeficiency Virus Infection J. Immunol., November 1, 2001; 167(9): 5429 - 5438. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Hislop, N. H. Gudgeon, M. F. C. Callan, C. Fazou, H. Hasegawa, M. Salmon, and A. B. Rickinson EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function J. Immunol., August 15, 2001; 167(4): 2019 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Faint, N. E. Annels, S. J. Curnow, P. Shields, D. Pilling, A. D. Hislop, L. Wu, A. N. Akbar, C. D. Buckley, P. A. H. Moss, et al. Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics J. Immunol., July 1, 2001; 167(1): 212 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Pittet, D. E. Speiser, D. Valmori, J.-C. Cerottini, and P. Romero Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression J. Immunol., February 1, 2000; 164(3): 1148 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Labalette, E. Leteurtre, C. Thumerelle, C. Grutzmacher, B. Tourvieille, and J.-P. Dessaint Peripheral human CD8+CD28+T lymphocytes give rise to CD28–progeny, but IL-4 prevents loss of CD28 expression Int. Immunol., August 1, 1999; 11(8): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Virts and W. C. Raschke The Role of Intron Sequences in High Level Expression from CD45 cDNA Constructs J. Biol. Chem., June 1, 2001; 276(23): 19913 - 19920. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fong, Y. Hou, A. Rivas, C. Benike, A. Yuen, G. A. Fisher, M. M. Davis, and E. G. Engleman Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy PNAS, July 17, 2001; 98(15): 8809 - 8814. [Abstract] [Full Text] [PDF] |
||||




